337 related articles for article (PubMed ID: 17724722)
21. Human Papilloma Virus Specific Immunogenicity and Dysfunction of CD8
Krishna S; Ulrich P; Wilson E; Parikh F; Narang P; Yang S; Read AK; Kim-Schulze S; Park JG; Posner M; Wilson Sayres MA; Sikora A; Anderson KS
Cancer Res; 2018 Nov; 78(21):6159-6170. PubMed ID: 30154146
[TBL] [Abstract][Full Text] [Related]
22. Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway.
Mora-García ML; Ávila-Ibarra LR; García-Rocha R; Weiss-Steider B; Hernández-Montes J; Don-López CA; Gutiérrez-Serrano V; Titla-Vilchis IJ; Fuentes-Castañeda MC; Monroy-Mora A; Jave-Suárez LF; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
Cell Immunol; 2017 Oct; 320():46-55. PubMed ID: 28950987
[TBL] [Abstract][Full Text] [Related]
23. Myeloid Cells Orchestrate Systemic Immunosuppression, Impairing the Efficacy of Immunotherapy against HPV
Galliverti G; Wullschleger S; Tichet M; Murugan D; Zangger N; Horton W; Korman AJ; Coussens LM; Swartz MA; Hanahan D
Cancer Immunol Res; 2020 Jan; 8(1):131-145. PubMed ID: 31771984
[TBL] [Abstract][Full Text] [Related]
24. The genetic variability, phylogeny and functional significance of E6, E7 and LCR in human papillomavirus type 52 isolates in Sichuan, China.
Song Z; Cui Y; Li Q; Deng J; Ding X; He J; Liu Y; Ju Z; Fang L
Virol J; 2021 May; 18(1):94. PubMed ID: 33941222
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus 16 E6/E7 contributes to immune escape and progression of cervical cancer by regulating miR-142-5p/PD-L1 axis.
Ling J; Sun Q; Tian Q; Shi H; Yang H; Ren J
Arch Biochem Biophys; 2022 Nov; 731():109449. PubMed ID: 36288761
[TBL] [Abstract][Full Text] [Related]
26. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
Combes JD; Pawlita M; Waterboer T; Hammouda D; Rajkumar T; Vanhems P; Snijders P; Herrero R; Franceschi S; Clifford G
Int J Cancer; 2014 Nov; 135(10):2453-61. PubMed ID: 24729277
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck Cancer.
Aggarwal C; Cohen RB; Morrow MP; Kraynyak KA; Sylvester AJ; Knoblock DM; Bauml JM; Weinstein GS; Lin A; Boyer J; Sakata L; Tan S; Anton A; Dickerson K; Mangrolia D; Vang R; Dallas M; Oyola S; Duff S; Esser M; Kumar R; Weiner D; Csiki I; Bagarazzi ML
Clin Cancer Res; 2019 Jan; 25(1):110-124. PubMed ID: 30242022
[TBL] [Abstract][Full Text] [Related]
28. Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China.
He J; Yang Y; Chen Z; Liu Y; Bao S; Zhao Y; Ding X
Virol J; 2019 May; 16(1):72. PubMed ID: 31138240
[TBL] [Abstract][Full Text] [Related]
29. Molecular and serologic markers of HPV 16 infection are associated with local recurrence in patients with oral cavity squamous cell carcinoma.
Huang CG; Lee LA; Liao CT; Yen TC; Yang SL; Liu YC; Li JC; Gong YN; Kang CJ; Huang SF; Fang KH; Chang KP; Lee LY; Hsueh C; Shih SR; Tsao KC
Oncotarget; 2017 May; 8(21):34820-34835. PubMed ID: 28422732
[TBL] [Abstract][Full Text] [Related]
30. KSHV co-infection down-regulates HPV16 E6 and E7 from cervical cancer cells.
Dai L; Cao Y; Jiang W; Zabaleta J; Liu Z; Qiao J; Qin Z
Oncotarget; 2017 May; 8(22):35792-35803. PubMed ID: 28415759
[TBL] [Abstract][Full Text] [Related]
31. Roles of E6 and E7 Human Papillomavirus Proteins in Molecular Pathogenesis of Cervical Cancer.
Taghizadeh E; Jahangiri S; Rostami D; Taheri F; Renani PG; Taghizadeh H; Gheibi Hayat SM
Curr Protein Pept Sci; 2019; 20(9):926-934. PubMed ID: 31244421
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Class I Major Histocompatibility Complex Gene Transcription in Human Tumors Caused by Human Papillomavirus Infection.
Gameiro SF; Zhang A; Ghasemi F; Barrett JW; Nichols AC; Mymryk JS
Viruses; 2017 Sep; 9(9):. PubMed ID: 28891951
[TBL] [Abstract][Full Text] [Related]
33. Phylogenetic analysis of Human papillomavirus 16 variants isolated from Indian Breast cancer patients showed difference in genetic diversity with that of cervical cancer isolates.
Islam S; Mazumder Indra D; Basu M; Roychowdhury A; Das P; Dasgupta H; Roy A; Alam N; Mondal RK; Roychoudhury S; Panda CK
Virus Res; 2018 Jan; 243():1-9. PubMed ID: 28988982
[TBL] [Abstract][Full Text] [Related]
34. Characterization of HPV18 E6-specific T cell responses and establishment of HPV18 E6-expressing tumor model.
Ma Y; Yang A; Peng S; Qiu J; Farmer E; Hung CF; Wu TC
Vaccine; 2017 Jul; 35(31):3850-3858. PubMed ID: 28599791
[TBL] [Abstract][Full Text] [Related]
35. Prevention and treatment of HPV-related cancer through a mRNA vaccine expressing APC-targeting antigen.
Li X; Wang H; Lai W; Liao J; Mo W; Huang K; He L; Liang X; Yu Z; Xu J; Hua X; Hou F; Ding J; Jia WW; Zhang K; Wang Y
Immunology; 2024 Jul; 172(3):375-391. PubMed ID: 38471664
[TBL] [Abstract][Full Text] [Related]
36. Expression and Significance of HPV16 E6/E7 mRNAs in the Bronchial Brush and TBNA Cells of Patients With Small Cell Lung Cancer.
Zou DJ; Zhao YB; Yang JH; Xu HT; Li QC; Wu GP
Technol Cancer Res Treat; 2021; 20():15330338211019505. PubMed ID: 34032147
[TBL] [Abstract][Full Text] [Related]
37. Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model.
Su L; Zhang Y; Zhang X; Liu T; Liu S; Li Y; Jiang M; Tang T; Shen H; Wang C
Sci Rep; 2021 Jun; 11(1):13404. PubMed ID: 34183739
[TBL] [Abstract][Full Text] [Related]
38. Naive and radiolabeled antibodies to E6 and E7 HPV-16 oncoproteins show pronounced antitumor activity in experimental cervical cancer.
Phaëton R; Gutierrez J; Jiang Z; Karabakhtsian RG; Albanese J; Sunkara J; Fisher DR; Goldberg GL; Dadachova E
Immunotherapy; 2015; 7(6):631-40. PubMed ID: 26098137
[TBL] [Abstract][Full Text] [Related]
39. IMMUNOLOGY OF CERVICAL CANCER.
Manzo-Merino J; Del-Toro-Arreola S; Rocha-Zavaleta L; Peralta-Zaragoza Ó; Jiménez-Lima R; Madrid-Marina V
Rev Invest Clin; 2020; 72(4):188-197. PubMed ID: 33064686
[TBL] [Abstract][Full Text] [Related]
40. Effects of Metformin on the virus/host cell crosstalk in human papillomavirus-positive cancer cells.
Hoppe-Seyler K; Herrmann AL; Däschle A; Kuhn BJ; Strobel TD; Lohrey C; Bulkescher J; Krijgsveld J; Hoppe-Seyler F
Int J Cancer; 2021 Sep; 149(5):1137-1149. PubMed ID: 33844847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
